SMG
Spectrum Management Group’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $32K | Hold |
600
| – | – | 0.01% | 159 |
|
2022
Q2 | $35K | Hold |
600
| – | – | 0.01% | 152 |
|
2022
Q1 | $46K | Hold |
600
| – | – | 0.01% | 163 |
|
2021
Q4 | $36K | Hold |
600
| – | – | 0.01% | 166 |
|
2021
Q3 | $34K | Hold |
600
| – | – | 0.01% | 208 |
|
2021
Q2 | $36K | Hold |
600
| – | – | 0.01% | 166 |
|
2021
Q1 | $42K | Hold |
600
| – | – | 0.01% | 154 |
|
2020
Q4 | $36K | Hold |
600
| – | – | 0.01% | 150 |
|
2020
Q3 | $36K | Hold |
600
| – | – | 0.01% | 157 |
|
2020
Q2 | $31K | Hold |
600
| – | – | 0.01% | 161 |
|
2020
Q1 | $20K | Hold |
600
| – | – | 0.01% | 160 |
|
2019
Q4 | $27K | Hold |
600
| – | – | 0.01% | 173 |
|
2019
Q3 | $23K | Hold |
600
| – | – | 0.01% | 168 |
|
2019
Q2 | $26K | Hold |
600
| – | – | 0.01% | 178 |
|
2019
Q1 | $23K | Hold |
600
| – | – | 0.01% | 170 |
|
2018
Q4 | $26K | Hold |
600
| – | – | 0.01% | 146 |
|
2018
Q3 | $29K | Hold |
600
| – | – | 0.01% | 150 |
|
2018
Q2 | $19K | Sell |
600
-4,018
| -87% | -$127K | 0.01% | 171 |
|
2018
Q1 | $144K | Hold |
4,618
| – | – | 0.05% | 88 |
|
2017
Q4 | $211K | Buy |
4,618
+200
| +5% | +$9.14K | 0.07% | 81 |
|
2017
Q3 | $166K | Buy |
+4,418
| New | +$166K | 0.05% | 124 |
|
2016
Q2 | – | Sell |
-4,018
| Closed | -$213K | – | 185 |
|
2016
Q1 | $213K | Hold |
4,018
| – | – | 0.08% | 80 |
|
2015
Q4 | $309K | Buy |
4,018
+360
| +10% | +$27.7K | 0.12% | 54 |
|
2015
Q3 | $150K | Buy |
3,658
+168
| +5% | +$6.89K | 0.08% | 56 |
|
2015
Q2 | $247K | Buy |
+3,490
| New | +$247K | 0.09% | 38 |
|
2015
Q1 | – | Sell |
-3,205
| Closed | -$284K | – | 134 |
|
2014
Q4 | $284K | Sell |
3,205
-90
| -3% | -$7.98K | 0.12% | 34 |
|
2014
Q3 | $319K | Sell |
3,295
-1,295
| -28% | -$125K | 0.2% | 33 |
|
2014
Q2 | $422K | Hold |
4,590
| – | – | 0.26% | 30 |
|
2014
Q1 | $321K | Buy |
4,590
+295
| +7% | +$20.6K | 0.23% | 30 |
|
2013
Q4 | $247K | Buy |
+4,295
| New | +$247K | 0.18% | 33 |
|